Multiple myeloma (MM) account for approximately 10% of hematological malignancies and is the second most common hematological disorder. Kinases inhibitors are widely used and their efficiency for the treatment of cancers has been demonstrated. Here. in order to identify kinases of potential therapeutic interest for the treatment of MM. https://storeanimalwiz.shop/product-category/valves-pipe/